$1.36
0.01[0.74%]
At close: Apr 22
$1.36
0[0.00%]
PreMarket: 7:00PM EDT
Connect Biopharma Hldgs
(NASDAQ:CNTB)Connect Biopharma Hldgs Stock (NASDAQ:CNTB), Analyst Ratings, Price Targets, Predictions
Connect Biopharma Holdings Ltd has a consensus price target of $9.7, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on April 17, 2024, March 4, 2024, and September 13, 2023. With an average price target of $6.67 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 390.20% upside for Connect Biopharma Holdings Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
SVB Leerink
Piper Sandler
CICC
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Connect Biopharma Hldgs
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 488.24% | HC Wainwright & Co. | Emily Bodnar | $7 → $8 | Maintains | Buy | Get Alert |
| 03/04/2024 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 414.71% | HC Wainwright & Co. | Emily Bodnar | → $7 | Initiates | → Buy | Get Alert |
| 09/13/2023 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 267.65% | Cantor Fitzgerald | Louise Chen | → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/08/2023 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 414.71% | SVB Leerink | Thomas Smith | $9 → $7 | Maintains | Outperform | Get Alert |
| 06/02/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 267.65% | Cantor Fitzgerald | Louise Chen | → $5 | Initiates | → Overweight | Get Alert |
| 05/05/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 10.29% | Piper Sandler | Joseph Catanzaro | $25 → $1.5 | Downgrade | Overweight → Neutral | Get Alert |
| 05/04/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 561.76% | SVB Leerink | Thomas Smith | $22 → $9 | Maintains | Outperform | Get Alert |
| 01/06/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 1517.65% | SVB Leerink | Thomas Smith | $32 → $22 | Maintains | Outperform | Get Alert |
| 07/02/2021 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.36 | 1885.29% | CICC | — | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Connect Biopharma Hldgs (CNTB)?
The latest price target for Connect Biopharma Hldgs (NASDAQ: CNTB) was reported by HC Wainwright & Co. on April 17, 2024. The analyst firm set a price target for $8.00 expecting CNTB to rise to within 12 months (a possible 488.24% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Connect Biopharma Hldgs (CNTB)?
The latest analyst rating for Connect Biopharma Hldgs (NASDAQ: CNTB) was provided by HC Wainwright & Co., and Connect Biopharma Hldgs maintained their buy rating.
When was the last upgrade for Connect Biopharma Hldgs (CNTB)?
There is no last upgrade for Connect Biopharma Hldgs.
When was the last downgrade for Connect Biopharma Hldgs (CNTB)?
The last downgrade for Connect Biopharma Holdings Ltd happened on May 5, 2022 when Piper Sandler changed their price target from $25 to $1.5 for Connect Biopharma Holdings Ltd.
When is the next analyst rating going to be posted or updated for Connect Biopharma Hldgs (CNTB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Connect Biopharma Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Connect Biopharma Hldgs was filed on April 17, 2024 so you should expect the next rating to be made available sometime around April 17, 2025.
Is the Analyst Rating Connect Biopharma Hldgs (CNTB) correct?
While ratings are subjective and will change, the latest Connect Biopharma Hldgs (CNTB) rating was a maintained with a price target of $7.00 to $8.00. The current price Connect Biopharma Hldgs (CNTB) is trading at is $1.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.